4-127939961-C-T
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 1P and 13B. PP3BP4_StrongBP6BS1BS2
The NM_001371596.2(MFSD8):c.590G>A(p.Gly197Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000344 in 1,613,454 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G197V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001371596.2 missense
Scores
Clinical Significance
Conservation
Publications
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosis 7Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P
- macular dystrophy with central cone involvementInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MFSD8 | NM_001371596.2 | c.590G>A | p.Gly197Asp | missense_variant | Exon 6 of 12 | ENST00000641686.2 | NP_001358525.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MFSD8 | ENST00000641686.2 | c.590G>A | p.Gly197Asp | missense_variant | Exon 6 of 12 | NM_001371596.2 | ENSP00000493218.2 |
Frequencies
GnomAD3 genomes AF: 0.00166 AC: 252AN: 152082Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000510 AC: 128AN: 251174 AF XY: 0.000420 show subpopulations
GnomAD4 exome AF: 0.000207 AC: 303AN: 1461254Hom.: 3 Cov.: 31 AF XY: 0.000183 AC XY: 133AN XY: 726930 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00166 AC: 252AN: 152200Hom.: 0 Cov.: 31 AF XY: 0.00168 AC XY: 125AN XY: 74414 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
BS1, PP3 -
Neuronal ceroid lipofuscinosis 7 Benign:2
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Late-infantile neuronal ceroid lipofuscinosis Uncertain:1
- -
not specified Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
MFSD8-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at